DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
World’s Largest Sickle Cell Disease Stem Cell Library Underway
Scientists in Boston are creating a stem cell library that could write a new chapter for far-reaching possibilities in sickle cell disease (SCD) research and innovative therapy development.
The library comprises sickle cell disease-specific induced pluripotent stem cells (iPSCs), which can can renew as many times as necessary without any type of differentiation, meaning they can be directed to grow as any tissue or organ. This characteristic makes iPSCs particularly helpful to create disease models in labs, helping scientists understand how diseases develop.
Related Content
-
news & eventsNew Sickle Cell Disease Research Shows Improved Patient OutcomesEmerging therapies and promising new ins...
-
education & researchOpioid use is not associated with in-hospital mortality among patients with sickle cell disease in the United StatesBackground: Vaso-occlusive pain crises ...
-
education & researchAmerican Society of Hematology 2020 Guidelines for Sickle Cell Disease: Management of Acute and Chronic PainObjective: These evidence-based guideli...
-
news & eventsSickle Cell Treatment Endari Now Available in the United StatesEmmaus Life Sciences has announced that ...
-
news & eventsIronwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disea...Ironwood Pharmaceuticals, Inc., a commer...
-
news & eventsIn France, Boy Becomes First Sickle Cell Disease Patient to be Treated With Gene TherapyA 13-year-old boy with sickle cell disea...
-
Community CenterHardships, and New Hope, for Sickle Cell PatientsSickle cell disease affects about 100,00...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.